Accelerated Neuroimmune Dysfunction in Aged HIV-1-Infected Humanized Mice

Chen Zhang,Hang Su,Emiko Waight,Larisa Y. Poluektova,Santhi Gorantla,Howard E. Gendelman,Prasanta K. Dash
DOI: https://doi.org/10.3390/ph17020149
IF: 4.6
2024-01-23
Pharmaceuticals
Abstract:Disordered immunity, aging, human immunodeficiency virus type one (HIV-1) infection, and responses to antiretroviral therapy are linked. However, how each factor is linked with the other(s) remains incompletely understood. It has been reported that accelerated aging, advanced HIV-1 infection, inflammation, and host genetic factors are associated with host cellular, mitochondrial, and metabolic alterations. However, the underlying mechanism remains elusive. With these questions in mind, we used chronically HIV-1-infected CD34-NSG humanized mice (hu-mice) to model older people living with HIV and uncover associations between HIV-1 infection and aging. Adult humanized mice were infected with HIV-1 at the age of 20 weeks and maintained for another 40 weeks before sacrifice. Animal brains were collected and subjected to transcriptomics, qPCR, and immunofluorescence assays to uncover immune disease-based biomarkers. CD4+ T cell decline was associated with viral level and age. Upregulated C1QA, CD163, and CXCL16 and downregulated LMNA and CLU were identified as age-associated genes tied to HIV-1 infection. Ingenuity pathway analysis affirmed links to innate immune activation, pyroptosis signaling, neuroinflammation, mitochondrial dysfunction, cellular senescence, and neuronal dysfunction. In summary, CD34-NSG humanized mice are identified as a valuable model for studying HIV-1-associated aging. Biomarkers of immune senescence and neuronal signaling are both age- and virus-associated. By exploring the underlying biological mechanisms that are linked to these biomarkers, interventions for next generation HIV-1-infected patients can be realized.
pharmacology & pharmacy,chemistry, medicinal
What problem does this paper attempt to address?
The problem that this paper attempts to solve is to explore the relationship between HIV - 1 infection and aging, especially the mechanism of accelerated aging in the central nervous system (CNS). The researchers used a long - term HIV - 1 - infected humanized mouse model to simulate the HIV infection situation in the elderly population, in order to reveal the association between HIV - 1 infection and aging and explore the biological mechanisms behind these associations. Specifically, the study focused on the following aspects: 1. **The impact of HIV - 1 infection on the immune system**: The study evaluated the impact of HIV - 1 infection on the immune system by analyzing the changes in the number of CD4+ T cells, especially the changes in elderly individuals. 2. **Gene expression changes**: Through transcriptomics analysis, the researchers identified gene expression changes related to HIV - 1 infection and aging, especially those related to immune function, neuroinflammation, mitochondrial dysfunction, cell senescence and neuronal dysfunction. 3. **Alterations in signaling pathways**: Using Ingenuity Pathway Analysis (IPA), the researchers further analyzed the alterations in signaling pathways related to HIV - 1 infection and aging, including innate immune activation, pyroptosis signaling, mitochondrial dysregulation, cell senescence and neuronal dysregulation. 4. **Histological verification**: Through immunofluorescence staining techniques, the researchers verified the transcriptomics data, especially the expression changes of neuronal, glial and oligodendrocyte markers in different regions of the brain. In summary, this paper aims to deeply understand how HIV - 1 infection affects the central nervous system of the elderly population through the humanized mouse model, as well as the molecular mechanisms behind this effect. This not only helps to explain the various health problems that occur during the aging process in HIV - 1 - infected patients, but also provides a theoretical basis for the development of new treatment strategies.